Autoimmune Disease Stem Cell Treatment
In this section, you will find all the necessary documentation that validates our data and processes. From placenta sourcing to stem cell certification, each document provides comprehensive evidence of our commitment to safety, quality, and transparency. Explore our certifications, quality reports, and compliance documents, ensuring you have complete confidence in our procedures and products.
This document provides comprehensive information on the research protocols and official registration of stem cells utilized in our regenerative medicine practices. It includes details on ethical sourcing, laboratory testing, and compliance with regulatory standards. The document guarantees transparency in our processes and affirms our commitment to safety, quality, and scientific rigor in stem cell therapies.
This document outlines the research protocols and official registration of placenta tissue used in our regenerative medicine processes. It provides detailed information on the ethical sourcing, testing, and compliance standards followed during the collection and processing phases. The document ensures transparency and adherence to regulatory requirements, demonstrating our commitment to safety and scientific integrity.
This document and certificate are issued by COFEPRIS (Federal Commission for Protection Against Health Risks), verifying that our regenerative medicine products and procedures adhere to strict regulatory standards. It ensures that all stem cell therapies and regenerative treatments meet the safety, quality, and ethical guidelines required by the regulatory authority, providing trust and confidence in our medical offerings.
This document and certificate, issued by COFEPRIS (Federal Commission for Protection Against Health Risks), confirm that our stem cell products and procedures comply with the stringent regulations and standards set by the regulatory authority. It ensures that our stem cell therapies meet the highest levels of safety, quality, and ethical guidelines, offering assurance and trust in our regenerative medicine practices.
Disclaimer for Celumed At Celumed, we are dedicated to providing advanced stem cell therapies aimed at improving health and wellness. However, it is important to understand that stem cell therapy does not offer guaranteed outcomes and is not promoted as a cure for medical conditions. This is consistent with the nature of many medical treatments, where responses can vary from patient to patient based on individual factors, including the severity of the condition, overall health, and adherence to post-treatment care. Stem cell therapy can offer significant benefits, but its success is not guaranteed. Eligibility for Treatment Before proceeding with stem cell therapy, a comprehensive review of the patient's medical history is necessary. This evaluation helps determine if the patient is a suitable candidate for the therapy and if it is likely to yield positive results. It is essential to ensure that the patient’s condition is appropriate for this type of treatment and that the therapy aligns with their medical needs. Use of Personal Information At Celumed, we prioritize your privacy and the security of your data. Any personal information provided by patients is strictly for internal and medical use only, and will be shared exclusively with our medical providers to facilitate the best possible care and treatment planning. All information is handled in compliance with relevant privacy laws. Reimbursement Policy Celumed offers a satisfaction guarantee on the services provided, but this policy excludes any reimbursement for specific treatments, products, or the associated expenses incurred during the treatment process. Our satisfaction guarantee only applies to the service quality and overall experience and is subject to Celumed’s specific terms and conditions. As such, it may not apply in all situations. Reimbursement policies for certain services and treatments are subject to specific terms established by Celumed and may vary depending on the case. Location and Regulatory Compliance All stem cell therapies are conducted at our state-of-the-art medical center located in Guadalajara, Jalisco, Mexico. Celumed operates under the regulatory framework of COFEPRIS, which is Mexico’s equivalent to the U.S. Food and Drug Administration (FDA). All treatments are performed in accordance with Mexico’s legal limits and regulations, ensuring that we meet the highest standards of care. These regulations ensure that all therapies are conducted safely and ethically, protecting the well-being of our patients. Limitation of Liability Patients receiving treatment at Celumed understand that stem cell therapy may not be suitable for everyone, and its effectiveness can vary. By undergoing treatment, patients acknowledge that they are doing so voluntarily and with full understanding of the potential risks and benefits. Celumed is not liable for any outcomes, including complications or unforeseen results, arising from the stem cell therapy. About Regenerative Medicine at Celumed At Celumed, we specialize in the use of mesenchymal stem cell (MSC) therapy, a cutting-edge approach in regenerative medicine aimed at treating a wide range of medical conditions. MSC therapy is being studied for its potential in healing damaged tissues, reducing inflammation, and improving organ function. Here are some recent studies and resources discussing MSC therapy for various diseases: 1.Congestive Heart Failure: A major study called DREAM-HF, involving over 500 patients with heart failure and reduced ejection fraction, showed that stem cell therapy reduced non-fatal heart attacks and strokes by 65%. It also reduced cardiac deaths by 80% for patients with higher inflammation markers. The therapy's anti-inflammatory properties appear to be particularly beneficial in conjunction with existing heart failure treatments American Heart Association https://newsroom.heart.org/news/stem-cell-therapy-for-heart-failure-reduced-major-cv-events-and-death-not-hospitalization 2.Fibromyalgia: While limited in large-scale clinical trials, mesenchymal stem cells have been studied for their potential to alleviate the pain and inflammation associated with fibromyalgia. The regenerative properties of MSCs might help restore damaged tissues and reduce chronic pain Oxford Academic https://academic.oup.com/stcltm/article/13/2/116/7450398 3.High Blood Pressure: Stem cell therapy is being explored as a potential treatment for high blood pressure, particularly for its ability to repair damage caused to blood vessels and the heart. MSCs are thought to improve endothelial function, which may help lower blood pressure levels American Heart Association https://newsroom.heart.org/news/stem-cell-therapy-for-heart-failure-reduced-major-cv-events-and-death-not-hospitalization 4.Kidney Disease: Research has highlighted MSCs' potential in treating chronic kidney disease (CKD), especially in improving kidney function and slowing the progression of kidney damage. The regenerative properties of MSCs are believed to help repair renal tissues Oxford Academic https://newsroom.heart.org/news/stem-cell-therapy-for-heart-failure-reduced-major-cv-events-and-death-not-hospitalization 5.Liver Disease: MSCs have shown promise in treating liver diseases, especially in repairing liver tissues and reducing fibrosis. Stem cell therapy may help regenerate damaged liver cells and improve overall liver function American Heart Association https://newsroom.heart.org/news/stem-cell-therapy-for-heart-failure-reduced-major-cv-events-and-death-not-hospitalization 6.Lupus and Autoimmune Diseases: MSCs have demonstrated their ability to modulate immune responses and may help control inflammation associated with autoimmune diseases like lupus. Clinical trials are still ongoing to understand their full potential Oxford Academic https://academic.oup.com/stcltm/article/13/2/116/7450398 7.Lyme Disease: Some studies suggest that stem cell therapy might help in cases of chronic Lyme disease, particularly by improving the immune response and helping to regenerate damaged tissues Oxford Academic https://academic.oup.com/stcltm/article/13/2/116/7450398 8.Myasthenia Gravis: Research is still emerging, but mesenchymal stem cells could play a role in managing this autoimmune disorder by potentially modulating the immune system and helping to regenerate nerve tissues Oxford Academic https://academic.oup.com/stcltm/article/13/2/116/7450398 9.Peripheral Neuropathy (Nerve Pain): MSC therapy is showing promise in reducing pain and improving nerve function in conditions like peripheral neuropathy, by repairing damaged nerves and regenerating nerve cells American Heart Association https://newsroom.heart.org/news/stem-cell-therapy-for-heart-failure-reduced-major-cv-events-and-death-not-hospitalization 10.Post-COVID Symptoms: MSCs are being investigated as a potential treatment for lingering symptoms of COVID-19, including respiratory issues, fatigue, and neurological damage. Their regenerative capabilities could assist in healing tissues and restoring function American Heart Association https://newsroom.heart.org/news/stem-cell-therapy-for-heart-failure-reduced-major-cv-events-and-death-not-hospitalization 11.Post-Heart Attack: Following a heart attack, MSC therapy has been studied for its ability to repair heart tissue and improve heart function. Clinical trials have shown positive results in reducing scar tissue and enhancing heart recovery American Heart Association https://newsroom.heart.org/news/stem-cell-therapy-for-heart-failure-reduced-major-cv-events-and-death-not-hospitalization 12.Psoriasis: Some research has suggested that MSCs could potentially help in treating psoriasis by modulating the immune system and reducing inflammation Oxford Academic https://academic.oup.com/stcltm/article/13/2/116/7450398 13.Rheumatoid Arthritis: MSCs are being explored for their potential to reduce inflammation and regenerate joint tissue, offering relief for patients suffering from rheumatoid arthritis Oxford Academic https://academic.oup.com/stcltm/article/13/2/116/7450398 14.Type-2 Diabetes: Stem cell therapies are being tested for their potential to regenerate pancreatic cells and improve insulin production, which could provide a novel treatment for Type-2 diabetes Oxford Academic https://academic.oup.com/stcltm/article/13/2/116/7450398 These findings illustrate the broad potential of MSCs across a variety of diseases, with ongoing research to validate their effectiveness. For more detailed studies, you can explore the articles and studies referenced in the links above. Stem cell therapy does not guarantee outcomes and is not presented as a cure, similar to many other medical treatments. To assess a patient's eligibility for stem cell therapy, a thorough review of their medical history is required. Any personal information provided remains confidential, used solely by our medical team for internal and clinical purposes. DBC Medical Center is located in Bucerias, Mexico, where all stem cell therapies are conducted under the regulation of COFEPRIS (the Mexican equivalent of the FDA) and other local health authorities. Treatments are strictly performed within the legal and regulatory framework governing medical practices in the country.
He completed his high school degree with a technical degree in clinical laboratory studies. His professional training in the field of medicine took place at the University of Guadalajara, where he received the title of surgeon and midwife with Professional Certificate 7802676. Additionally, he completed a master’s degree in aesthetic and regenerative medicine, which has sparked a special interest in cellular therapies and regenerative medicine, including various training courses on the subject. His professional development has focused on providing first contact medical care, minor surgical procedures, non-invasive aesthetic medicine, and management of minor emergencies. As a teacher he has taught courses, seminars, and theoretical-practical workshops in regenerative and aesthetic medicine. Currently, I have more than 13 years of experience in the field of regenerative medicine and cellular therapies, actively collaborating in research protocols and being a speaker on various topics related to the field. He is continually motivated to expand his knowledge and regularly pursues certification programs to stay updated on new techniques and skills in regenerative medicine.